Such bleeding disorders in patients with ARPC1B deficiency have been associated with mild platelet dysfunction and aggregation defect, slight reduction of CD62P and CD63 molecules (15), as well as defects in platelets size and morphology with the reduction of calcium-rich platelets dense granules and the inability to form lamellipodia necessary for actin branching (5). This evidence concerns the gene CD63 and hemorrhagic disease.